JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 180 filers reported holding JUNO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.57 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $70,000 | +12.9% | 1,515 | +10.3% | 0.00% | – |
| Q3 2017 | $62,000 | +34.8% | 1,373 | -12.4% | 0.00% | – |
| Q2 2017 | $46,000 | +31.4% | 1,568 | 0.0% | 0.00% | – |
| Q1 2017 | $35,000 | +20.7% | 1,568 | +0.6% | 0.00% | – |
| Q4 2016 | $29,000 | -50.0% | 1,558 | -18.0% | 0.00% | – |
| Q3 2016 | $58,000 | +81.2% | 1,900 | +137.5% | 0.00% | – |
| Q2 2016 | $32,000 | +33.3% | 800 | +33.3% | 0.00% | – |
| Q1 2016 | $24,000 | -46.7% | 600 | -40.0% | 0.00% | – |
| Q4 2015 | $45,000 | +40.6% | 1,000 | +23.6% | 0.00% | – |
| Q3 2015 | $32,000 | -87.5% | 809 | -83.1% | 0.00% | – |
| Q2 2015 | $256,000 | +433.3% | 4,800 | +500.0% | 0.00% | – |
| Q1 2015 | $48,000 | -56.0% | 800 | -61.9% | 0.00% | – |
| Q4 2014 | $109,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,055,857,000 | 100.00% |
| Omega Fund Management, LLC | 1,329,512 | $54,098,000 | 30.46% |
| SOUND ENERGY PARTNERS, INC. | 25,800 | $1,050,000 | 2.12% |
| Graticule Asia Macro Advisors LLC | 435,205 | $17,708,000 | 2.06% |
| BB BIOTECH AG | 1,305,000 | $53,100,000 | 1.68% |
| Kazazian Asset Management, LLC | 13,376 | $544,000 | 0.69% |
| Rock Springs Capital Management LP | 197,001 | $8,016,000 | 0.65% |
| TURNER INVESTMENTS LLC | 69,680 | $2,835,000 | 0.57% |
| MIZUHO SECURITIES USA LLC | 49,600 | $2,018,000 | 0.52% |
| Private Capital Advisors, Inc. | 27,900 | $1,135,000 | 0.48% |